Literature DB >> 8256846

Detection of anti-sense transcripts of the insulin-like growth factor-2 gene in Wilms' tumor.

P Baccarini1, M Fiorentino, A D'Errico, A M Mancini, W F Grigioni.   

Abstract

The expression of the insulin-like growth factor-2 (IGF-2) gene was studied by means of both in situ hybridization and immunohistochemistry in eight cases of Wilms' tumor with different histological features. An anti-sense cRNA IGF-2 probe revealed the presence of abundant IGF-2 mRNAs in all eight tumors examined, localized in the most undifferentiated tumoral cells (blastemal cells); none of the tumors showed immunoreactivity for the anti-IGF-2 antibody. Using a sense cRNA IGF-2 probe, we also detected anti-sense transcripts of the IGF-2 gene in five of eight tumors. These transcripts were exclusively localized in the cells expressing the IGF-2 mRNAs. Although the function of these anti-sense transcripts is unknown, we think that their presence could explain the lack of IGF-2 peptides in Wilms' tumors despite increased expression of IGF-2 mRNAs.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8256846      PMCID: PMC1887269     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  27 in total

Review 1.  The role of insulin-like growth factors and IGF-binding proteins in the physiological and pathological processes of the kidney.

Authors:  W Zumkeller; P N Schofield
Journal:  Virchows Arch B Cell Pathol Incl Mol Pathol       Date:  1992

Review 2.  Actions of insulin-like growth factors.

Authors:  E R Froesch; C Schmid; J Schwander; J Zapf
Journal:  Annu Rev Physiol       Date:  1985       Impact factor: 19.318

3.  A unique mechanism regulating gene expression: translational inhibition by a complementary RNA transcript (micRNA).

Authors:  T Mizuno; M Y Chou; M Inouye
Journal:  Proc Natl Acad Sci U S A       Date:  1984-04       Impact factor: 11.205

4.  Insulin-like growth factor II in human adrenal pheochromocytomas and Wilms tumors: expression at the mRNA and protein level.

Authors:  G K Haselbacher; J C Irminger; J Zapf; W H Ziegler; R E Humbel
Journal:  Proc Natl Acad Sci U S A       Date:  1987-02       Impact factor: 11.205

5.  Insulin-like growth factor II precursor gene organization in relation to insulin gene family.

Authors:  T J Dull; A Gray; J S Hayflick; A Ullrich
Journal:  Nature       Date:  1984 Aug 30-Sep 5       Impact factor: 49.962

6.  Two mammalian genes transcribed from opposite strands of the same DNA locus.

Authors:  J P Adelman; C T Bond; J Douglass; E Herbert
Journal:  Science       Date:  1987-03-20       Impact factor: 47.728

7.  Expression of insulin-like growth factor-II transcripts in Wilms' tumour.

Authors:  A E Reeve; M R Eccles; R J Wilkins; G I Bell; L J Millow
Journal:  Nature       Date:  1985 Sep 19-25       Impact factor: 49.962

8.  Insulin-like growth factor-II gene expression in Wilms' tumour and embryonic tissues.

Authors:  J Scott; J Cowell; M E Robertson; L M Priestley; R Wadey; B Hopkins; J Pritchard; G I Bell; L B Rall; C F Graham
Journal:  Nature       Date:  1985 Sep 19-25       Impact factor: 49.962

Review 9.  Wilms' tumor and other renal tumors of childhood: a selective review from the National Wilms' Tumor Study Pathology Center.

Authors:  J B Beckwith
Journal:  Hum Pathol       Date:  1983-06       Impact factor: 3.466

10.  Developmental regulation of insulin-like growth factor II mRNA in different rat tissues.

Authors:  A L Brown; D E Graham; S P Nissley; D J Hill; A J Strain; M M Rechler
Journal:  J Biol Chem       Date:  1986-10-05       Impact factor: 5.157

View more
  4 in total

1.  IGF-II dependent autocrine growth in cell lines derived from renal tumours of childhood.

Authors:  W Zumkeller; A Mahmood; R Dellow; P N Schofield
Journal:  Clin Mol Pathol       Date:  1995-12

Review 2.  Genomic imprinting: mechanism and role in human pathology.

Authors:  B Tycko
Journal:  Am J Pathol       Date:  1994-03       Impact factor: 4.307

3.  Pituitary Insulin: Insulin-Like Growth Factors.

Authors:  Shunichi Yokoyama; Lucia Stefaneanu; Kalman Kovacs
Journal:  Endocr Pathol       Date:  1997       Impact factor: 3.943

4.  Deoxyribozymes: new therapeutics to treat central nervous system disorders.

Authors:  Barbara Grimpe
Journal:  Front Mol Neurosci       Date:  2011-09-23       Impact factor: 5.639

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.